IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$219M
AUM Growth
-$58.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$7.63M
2
+$6.9M
3
+$5.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.53M
5
LLY icon
Eli Lilly
LLY
+$2.77M

Top Sells

1
+$10.8M
2
+$10.3M
3
+$8.32M
4
GILD icon
Gilead Sciences
GILD
+$4.18M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.71M

Sector Composition

1 Healthcare 96.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$18.5M 8.44%
77,822
-15,600
2
$17.7M 8.08%
237,284
-56,000
3
$14.5M 6.59%
45,700
4
$14.3M 6.54%
169,784
+65,500
5
$14.2M 6.49%
337,000
+1,000
6
$13.4M 6.1%
66,000
7
$12M 5.46%
269,000
+155,000
8
$11.7M 5.32%
394,000
+4,000
9
$9.29M 4.23%
107,300
-26,000
10
$7.63M 3.48%
+190,000
11
$7.29M 3.32%
99,500
+35,500
12
$6.96M 3.17%
281,797
+239,097
13
$6.61M 3.01%
73,641
-12,500
14
$6.56M 2.99%
56,900
-7,100
15
$6.4M 2.92%
87,194
+210
16
$5.53M 2.52%
307,633
17
$3.37M 1.54%
43,900
+8,000
18
$2.77M 1.26%
+20,000
19
$2.74M 1.25%
28,100
-12,000
20
$2.54M 1.16%
53,781
21
$2.42M 1.11%
22,300
-21,000
22
$2.38M 1.09%
+46,500
23
$1.78M 0.81%
103,534
24
$1.73M 0.79%
227,433
-50,000
25
$1.62M 0.74%
18,000
-39,000
1
2 3